Source:http://linkedlifedata.com/resource/pubmed/id/12529276
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-1-16
|
pubmed:abstractText |
Renal interstitial inflammation is an important factor in the pathogenesis of chronic cyclosporin A (CsA) nephropathy. We studied the expression of the chemoattractant osteopontin (OPN) and the relationship between OPN expression and tubulointerstitial injury in a rat model of chronic CsA nephropathy. Chronic CsA nephropathy was induced in Sprague-Dawley rats by administering CsA (15 mg/kg sc) for 5 wk and then withdrawing it for 5 or 10 wk. Renal function, histopathology (arteriolopathy, ED-1-positive cells, and tubulointerstitial fibrosis), renin-angiotensin system (RAS) activity, and OPN expression were observed during the follow-up period. Renal function deteriorated in CsA-treated rats, with the development of typical histopathology and activation of RAS. After CsA withdrawal, these parameters were significantly reversed (all P < 0.05). The upregulation of OPN mRNA and protein expression seen in CsA-treated rat kidneys was decreased 5 wk after CsA withdrawal and was further decreased after 10 wk. Of note, OPN mRNA expression correlated with the number of infiltrating macrophage (r = 0.651, P < 0.01) and tubulointerstitial fibrosis (r = 0.729, P < 0.01). These findings suggest that OPN expression and macrophage infiltration decrease after long-term CsA withdrawal in rats with established chronic CsA nephropathy, and this is closely associated with recovery from renal injury.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Osteopontin,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/Sialoglycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Spp1 protein, rat
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1931-857X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
F389-98
|
pubmed:dateRevised |
2011-4-28
|
pubmed:meshHeading |
pubmed-meshheading:12529276-Animals,
pubmed-meshheading:12529276-Chronic Disease,
pubmed-meshheading:12529276-Cyclosporine,
pubmed-meshheading:12529276-Drug Administration Schedule,
pubmed-meshheading:12529276-Immunosuppressive Agents,
pubmed-meshheading:12529276-Kidney,
pubmed-meshheading:12529276-Kidney Diseases,
pubmed-meshheading:12529276-Macrophages,
pubmed-meshheading:12529276-Male,
pubmed-meshheading:12529276-Osteopontin,
pubmed-meshheading:12529276-Rats,
pubmed-meshheading:12529276-Rats, Sprague-Dawley,
pubmed-meshheading:12529276-Renin,
pubmed-meshheading:12529276-Renin-Angiotensin System,
pubmed-meshheading:12529276-Sialoglycoproteins
|
pubmed:year |
2003
|
pubmed:articleTitle |
Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
|
pubmed:affiliation |
Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|